Newsroom

Learn more about Recolony bacteria-based cancer therapy, plus never miss an event.

Feb 23, 20231 min read

Recolony receives CHF 150,000 from Venture Kick

Recolony wins the Stage III of Venture Kick. Recolony will invest the CHF 150,000 awarded by Venture Kick to advance our small molecule...